BACKGROUND: Physical activity may influence ovarian cancer risk through hormonal, inflammatory, or immune-mediated processes or by suppressing ovulation. In a population-based case-control study of epithelial ovarian cancer, we assessed risk associated with recreational physical activity with a focus on characterizing risk within histologic subtypes. METHODS: Information was collected during in-person interviews with 812 women with ovarian cancer diagnosed in western Washington State from 2002-2005 and 1,313 controls. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Exercise was assessed according to the average hours and metabolic equivalent (MET)-hours per week and the number of years in which regular recreational activity occurred. RESULTS: Relative to women who reported no regular exercise throughout adulthood, the overall risk of invasive, but not borderline, ovarian cancer was reduced among more active women. Reductions in risk of invasive disease were most evident among women with the greatest frequency of high-intensity activity during adulthood. For serous invasive cancer, women in the uppermost category of MET-hours per week of recreational activity in adulthood had 60% the risk of inactive women (95% CI 0.4-0.9), whereas this level of activity was associated with more than a doubling in risk of endometrioid and clear cell invasive tumors. CONCLUSIONS: Our findings are compatible with an overall reduction in risk of invasive epithelial ovarian cancer associated with recreational activity but suggest that this association may differ in women with different histologic types of disease. Inconsistent findings across studies that have considered histologic type indicate that this issue is not yet resolved.
BACKGROUND: Physical activity may influence ovarian cancer risk through hormonal, inflammatory, or immune-mediated processes or by suppressing ovulation. In a population-based case-control study of epithelial ovarian cancer, we assessed risk associated with recreational physical activity with a focus on characterizing risk within histologic subtypes. METHODS: Information was collected during in-person interviews with 812 women with ovarian cancer diagnosed in western Washington State from 2002-2005 and 1,313 controls. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Exercise was assessed according to the average hours and metabolic equivalent (MET)-hours per week and the number of years in which regular recreational activity occurred. RESULTS: Relative to women who reported no regular exercise throughout adulthood, the overall risk of invasive, but not borderline, ovarian cancer was reduced among more active women. Reductions in risk of invasive disease were most evident among women with the greatest frequency of high-intensity activity during adulthood. For serous invasive cancer, women in the uppermost category of MET-hours per week of recreational activity in adulthood had 60% the risk of inactive women (95% CI 0.4-0.9), whereas this level of activity was associated with more than a doubling in risk of endometrioid and clear cell invasive tumors. CONCLUSIONS: Our findings are compatible with an overall reduction in risk of invasive epithelial ovarian cancer associated with recreational activity but suggest that this association may differ in women with different histologic types of disease. Inconsistent findings across studies that have considered histologic type indicate that this issue is not yet resolved.
Authors: Petra H Lahmann; Christine Friedenreich; Mandy Schulz; Anne E Cust; Annekatrin Lukanova; Rudolf Kaaks; Anne Tjønneland; Nina Føns Johnsen; Kim Overvad; Agnès Fournier; Marie-Christine Boutron-Ruault; Françoise Clavel Chapelon; Heiner Boeing; Jakob Linseisen; Sabine Rohrmann; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Amalia Mattiello; Carlotta Sacerdote; Claudia Agnoli; Rosario Tumino; J Ramón Quirós; Nerea Larrañaga; Antonio T Agudo; Maria-José Sánchez; Göran Berglund; Jonas Manjer; Evelyn M Monninkhof; Petra H M Peeters; H Bas Bueno-de-Mesquita; Anne M May; Naomi Allen; Kay Tee Khaw; Sheila Bingham; Sabina Rinaldi; Pietro Ferrari; Elio Riboli Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-01 Impact factor: 4.254
Authors: Peter Schnohr; Morten Grønbaek; Liselotte Petersen; Hans Ole Hein; Thorkild I A Sørensen Journal: Scand J Public Health Date: 2005 Impact factor: 3.021
Authors: E R Bertone; W C Willett; B A Rosner; D J Hunter; C S Fuchs; F E Speizer; G A Colditz; S E Hankinson Journal: J Natl Cancer Inst Date: 2001-06-20 Impact factor: 13.506
Authors: Tomas Riman; Paul W Dickman; Staffan Nilsson; Hans Nordlinder; Cecilia M Magnusson; Ingemar R Persson Journal: Eur J Epidemiol Date: 2004 Impact factor: 8.082
Authors: Catherine M Olsen; Christopher J Bain; Susan J Jordan; Christina M Nagle; Adèle C Green; David C Whiteman; Penelope M Webb Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11 Impact factor: 4.254
Authors: Alpa V Patel; Carmen Rodriguez; Alexandre L Pavluck; Michael J Thun; Eugenia E Calle Journal: Am J Epidemiol Date: 2006-02-22 Impact factor: 4.897
Authors: Mary Anne Rossing; Kara L Cushing-Haugen; Kristine G Wicklund; Jennifer A Doherty; Noel S Weiss Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-12 Impact factor: 4.254
Authors: Mary Anne Rossing; Kara L Cushing-Haugen; Kristine G Wicklund; Noel S Weiss Journal: Cancer Causes Control Date: 2007-12-15 Impact factor: 2.506
Authors: Urmila Chandran; Elisa V Bandera; Melony G Williams-King; Lisa E Paddock; Lorna Rodriguez-Rodriguez; Shou-En Lu; Shameka Faulkner; Katherine Pulick; Sara H Olson Journal: Cancer Causes Control Date: 2011-02-01 Impact factor: 2.506
Authors: Qian Xiao; Hannah P Yang; Nicolas Wentzensen; Albert Hollenbeck; Charles E Matthews Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-08-21 Impact factor: 4.254
Authors: Sarah E Abbott; Elisa V Bandera; Bo Qin; Lauren C Peres; Patricia G Moorman; Jill Barnholtz-Sloan; Ann G Schwartz; Ellen Funkhouser; Edward S Peters; Michele L Cote; Anthony J Alberg; Paul Terry; Melissa Bondy; Lisa E Paddock; Sydnee Crankshaw; Frances Wang; Fabian Camacho; Joellen M Schildkraut Journal: Cancer Med Date: 2016-02-29 Impact factor: 4.452